TRENTON, N.J. (AP) - Merck & Co. on Tuesday posted a $1.63 billion loss in the fourth quarter as whopping charges, mainly for its Vioxx litigation settlement, dragged down results. The maker of allergy and asthma pill Singulair and osteoporosis treatment Fosamax said the net loss amounted to 75 cents…

Originally Syndicated via RSS from Yahoo! News Search Results for vioxx